The first thing that needs to be clear is that hospitals do not provide dental stem cell storage. Dental stem cell storage is divided into: tooth collection, stem cell extraction, testing, preparation, freezing and other steps, dental hospitals with the collection of teeth, while the extraction of milk teeth stem cells, testing, preparation and other operations will be carried out by professional storage organizations.
What are the benefits of milk teeth stem cell storage
As a kind of pluripotent stem cells, milk teeth stem cells can be differentiated into a variety of human functional cells under the induction of specific conditions, and their differentiation and regeneration ability is more than 3 times of other stem cells. Scientific research has shown that dental stem cells can have good effect on the intervention and treatment of more than 200 kinds of diseases, such as periodontitis, pulp regeneration, periodontal regeneration, rheumatoid arthritis, Parkinson's disease, Alzheimer's disease, cardiomyopathy, diabetes mellitus, coronary artery disease, cirrhosis of the liver and so on, and also widely used in the fields of cosmetic and anti-aging, and sub-health care, which is of high scientific research and medical value. The immunogenicity of the mastoid stem cells is low, and no matching is required for the use of relatives within three generations, so the whole family can benefit from the storage of one person.
How to choose a storage organization for mammary stem cells
When storing mammary stem cells, it is important to be careful when choosing a storage organization, and to identify whether it has professional qualifications, such as: whether it is approved by the state, whether it has a laboratory that meets the GMP level, and whether it has the appropriate technology and equipment for collecting mammary stem cells, etc., and it is best to conduct a site visit.
It is understood that there are not many organizations that have the qualification of storing milk teeth stem cells in China, and experts in the industry recommend ICP Dental Bank.
Scale advantage: located in the Beijing Economic and Technological Development Jinghai Industrial Park, the building has a total area of 2500 square meters, divided into the upper and lower two layers. The first floor is a pavilion-style interactive experience area, which is divided into three exhibition halls, namely Decoding Life, Source of Life and Life Bank; the second floor is the stem cell tissue bank of ICP Dental Bank, with a storage capacity of 500,000 copies.
Equipment Advantage: We have introduced the world's most advanced AXP automatic stem cell separation equipment, the latest flow cytometer, PCR instrument, program-controlled cooling instrument, DNA sequencer, automatic Bio-Achive stem cell preservation equipment, and other international advanced brand of medical-grade instruments and equipment.
Technical Advantage: The research team not only has academician Wu Zuze, who is known as the "Father of China's Hematopoietic Stem Cells", but also gathers many authoritative experts and academicians in the field of stem cells, such as Zhang Yuanyuan, Director of the Tissue Cell Therapy Center of the Institute of Regenerative Medicine of Wake Forest University, Wei Shicheng, Director of the Research Center of the Peking University Stomatology Hospital, and Wei Shicheng, Director of the Research Center of the Peking University Stomatology Hospital. Wei Shicheng, Director of the Research Center of Peking University Stomatology Hospital, and Ge Lihong, Director of Children's Stomatology Department of Peking University School of Stomatology, etc.
Translational Advantage: Stem cell research platforms have been set up with a number of domestic and foreign universities, such as Peking University's Institute of Frontier Interdisciplinary Research, Wake Forest University in the U.S.A., to carry out scientific research in the areas of stem cells and tissue engineering. At the same time, we also work with many tertiary hospitals, such as Peking University Stomatology, to conduct stem cell-related clinical trials, fully responding to the national policy of "industry-academia-research" as a whole, and contributing to the research and application of stem cells in China.